3Nizankowska E,Bestynska-Krypel A,Cmiel A,et al.Oral and bronchial provocation tests with aspirin for diagnosis of aspirininduced asthma.Eur Respir J,2000,15:863.
4Samter M,Beors RF.Intolerance to aspirin:clinical studies and consideration of its pathogenesis.Ann Intern Med,1968,68:975-983.
5Stevenson DD,Simon RA.Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma.J Allergy Clin Immunol,2001,108(1):47-51.
6Tries S,Neupert W,Lanfer S.The mechanism of action of the new antiinflammatory compound ML3000:inhibition of 5-LOX and COX-1/2.inflamm Res,2002,51(3):135-143.
7Dahlen SE, Malmstrom K, Nizankowska E, et al. Improvement of aspirinintolerant asthma by montelukast,a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial[J]. Am J Respir Crit Care Med, 2002, 165(1):9.
8Samter M, Beers RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis[J]. Ann Intern Med, 1968, 68:975.
9Szczeklik A. Mechanism of aspirin induced asthma[J]. Allergy, 1997,52,613.
10Holgate ST Bradding P, SAMPSON ap. Leukotriene antagonist and syndthesis inhibitors: new directions in asthma therapy [J]. J Allergy Clin Immunol,1996,98:1.
2Dahl6n B. Treatment of aspirin-intolerant asthma with antileukotri- enes[J]. Am J Respir Crit Care Med,2000,161 (2) :S137-S141.
3Price DB, Hernandez D, Magyar P, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma[ J]. Thorax,2003,58 ( 1 ) : 211-216.
